HOME ＞ 研究業績詳細
研究業績詳細
深田 浩大（フカダ ヒロオ）
| 研究テーマ | 消化器病、肝臓病、クッパー細胞、オートファジー |
|---|---|
| 研究業績（論文） | Hepatic steatosis and skeletal muscle alterations during the COVID-19 lockdown in a cohort of patients with chronic liver disease in Japan. Uchiyama A, Kon K, Sakuma S, Sato T, Morinaga M, Fukada H, Yamagata H, Yaginuma R, Fukuhara K, Yamashina S, Nojiri S, Ikejima K. Hepatol Res. 54 272-283 2024 The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension. Saeki M, Okubo H, Takasaki Y, Nakadera E, Fukuo Y, Fukada H, Hotchi Y, Maruyama H, Kokubu S, Shiina S, Nagahara A, Ikejima K. J Clin Med. 12 2662 2023 Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease. Morinaga M, Kon K, Uchiyama A, Fukada H, Fukuhara K, Yaginuma R, Nakadera E, Yamashina S, Ikejima K. Hepatol Int. 16 348-358 2022 Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites. Sagawa E, Okubo H, Ando H, Sorin Y, Kanazawa R, Nakadera E, Fukada H, Kokubu S, Miyazaki A. J Pharmacol Sci. 139 373-376 2019 Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C. Okubo H, Ando H, Sorin Y, Nakadera E, Fukada H, Morishige J, Miyazaki A, Ikejima K. PLoS One. 13 e0196747 2018 Use of finger-piece method for indocyanine green clearance test. Sagawa E, Okubo H, Sorin Y, Nakadera E, Fukada H, Igusa Y, Kokubu S, Miyazaki A, Watanobe I, Sugo H, Kojima K, Watanabe S. Hepatol Res. 47 1235-1240 2017 Gadoxetic Acid-Enhanced MR Imaging Predicts Simeprevir-Induced Hyperbilirubinemia During Hepatitis C Virus Treatment: A Pilot Study. Okubo H, Kitamura T, Ando H, Fukada H, Igusa Y, Kokubu S, Miyazaki A, Fujimura A, Shiina S, Watanabe S. J Clin Pharmacol. 57 369-375 2017 Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation. Serizawa N, Tian J, Fukada H, Baghy K, Scott F, Chen X, Kiss Z, Olson K, Hsu D, Liu FT, Török NJ, Zhao B, Jiang JX. Lab Invest, 95 1145-1156 2015 Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. Jiang JX, Chen X, Fukada H, Serizawa N, Devaraj S, Török NJ. Hepatology. 58(4) 1339-1348 2013 Suppression of autophagy sensitizes Kupffer cells to endotoxin. Fukada H, Yamashina S, Izumi K, Komatsu M, Tanaka K, Ikejima K, Watanabe S. Hepatol Res. 42(11) 1112-1118 2012 Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Jiang JX, Chen X, Hsu DK, Baghy K, Serizawa N, Scott F, Takada Y, Takada Y, Fukada H, Chen J, Devaraj S, Adamson R, Liu FT, Török NJ. Am J Physiol Gastrointest Liver Physiol. 302(4) G439-446 2012 Loss of autophagy promotes murine acetaminophen hepatotoxicity. Igusa Y, Yamashina S, Izumi K, Inami Y, Fukada H, Komatsu M, Tanaka K, Ikejima K, Watanabe S. J Gastroenterol. 47(4) 433-443 2012 |
| 研究者 | 教育活動 |